NCT02182206View on ClinicalTrials.gov

An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2005

Conditions
Tumors
Interventions
DRUG

BIBF 1120

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY